Headline
The latest stories from AHA Today.
A new AHA issue brief outlines five actions that hospitals and health systems can take to address housing instability and improve health in their communities during COVID-19.
Kittitas Valley Healthcare in Ellensburg, Wash., was among the nation’s first hospitals to feel the impact of COVID-19.
The Food and Drug Administration issued emergency use authorizations to Xiamen Biotime Biotechnology Co. and Access Bio Inc. for serology-based tests to detect SARS-CoV-2 antibodies indicating recent or prior infection.
The U.S. International Development Finance Corporation signed a letter of interest to provide a $765 million loan to Eastman Kodak Company to repurpose and expand its facilities in Rochester, N.Y., and St. Paul, Minn., to produce active pharmaceutical ingredients in short supply.
The Department of Health and Human Services’ Biomedical Advanced Research and Development Authority issued a $265 million task order reserving vaccine manufacturing capacity through December 2021 at an advanced manufacturing center in Texas.
The Centers for Medicare & Medicaid Services released an updated snapshot of the impact of COVID-19 on the Medicare population, which includes COVID-19 cases and hospitalizations through June 20 and the first data for American Indian/Alaskan Native Medicare beneficiaries.
The National Association of Medicaid Directors asked the Centers for Medicare & Medicaid Services to suspend finalizing the Medicaid Fiscal Accountability Rule while states respond to the COVID-19 pandemic and its impact on state budgets.
Senate Republicans released a series of bills aimed at addressing the COVID-19 pandemic.
The AHA announced it is honoring five hospital-led partnerships with the AHA Dick Davidson NOVA Award for each program’s efforts to improve community health.
President Trump signed three executive orders aimed at lowering the price of prescription drugs, with actions targeting federally qualified health center insulin and EpiPen discounts; the importation and re-importation of prescription drugs from foreign countries; and drug manufacturer rebates and…